In this study, sequential cardiopulmonary exercise testing was used to assess the physiologic benefits of a single-chamber ventricular pacing system that utilizes a piezoceramic sensor to adjust heart rate by detecting "physical activity." An initial exercise test was conducted with the pacemaker programmed (based on a randomization 2.5 min; p < .01), (3) increased peak oxygen consumption (VVI-Act 1617 656 ml 02/min vs VVI 1325 ± 451 ml 02/min; p < .01), and (4) onset of anaerobic threshold at a higher oxygen consumption (VVI-Act 1208 ± 343 ml 02/min vs VVI 1064 + 377 ml 02/min: p < .01). Additionally, of 44 comparable exercise stages tested in the two pacing modes, perceived exertion (assessed by a numerical grading system) was lower in 38 of 44 instances during VVI-Act compared with VVI pacing. Thus provision of chronotropic response during exercise by single chamber rate-variable ventricular pacing substantially improved exercise tolerance and therefore may be of benefit for patients with bradycardia-related symptoms in whom associated sinoatrial disease or difficulty establishing or maintaining atrial sensing preclude optimum function of conventional atrial-tracking pacing systems. Circulation 75, No. 1, 184-191, 1987. OPTIMAL CARDIAC PACING provides both atrioventricular (AV) synchrony and a physiologically appropriate heart rate. 2 To achieve these goals, both atrial synchronous (VDD) and universal (DDD) pacing modes track native atrial rate and pace the ventricles after a preset AV interval. However